Monika Brüggemann

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 32

Top Venues

Blood

Leukemia

Blood advances

Molecular diagnosis & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Neumann, Thomas Beder, Lorenz Bastian, Sonja Hänzelmann, Miriam Bultmann, Nadine Wolgast, Alina Hartmann, Heiko Trautmann, Jutta Ortiz-Tanchez, Cornelia Schlee, Michael Schroeder, Lars Fransecky, Sebastian Vosberg, Walter Fiedler, Nael Alakel, Lisa Heberling, Mustafa Kondakci, Michael Starck, Stefan Schwartz, Simon Raffel, Carsten Müller-Tidow, Folker Schneller, Albrecht Reichle, Thomas Burmeister, Philipp A Greif, Monika Brüggemann, Nicola Gökbuget, Claudia Dorothea Baldus
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols. Leukemia (2024)
Michaela Kotrová, Eva Froňková, Michael Svatoň, Daniela Drandi, Felix Schön, Patricia Hoogeveen, Jeremy Hancock, Aneta Skotnicova, Anke Schilhabel, Cornelia Eckert, Emmanuelle Clappier, Giovanni Cazzaniga, Beat W Schäfer, Jacques J M van Dongen, Matthias Ritgen, Christiane Pott, Vincent H J van der Velden, Jan Trka, Monika Brüggemann
The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category. Leukemia (2024)
Moritz Fürstenau, Adam Giza, Jonathan Weiss, Fanni Kleinert, Sandra Robrecht, Fabian Franzen, Janina Stumpf, Petra Langerbeins, Othman Al-Sawaf, Florian Simon, Anna-Maria Fink, Christof Schneider, Eugen Tausch, Johannes Schetelig, Peter Dreger, Sebastian Böttcher, Kirsten Fischer, Karl-Anton Kreuzer, Matthias Ritgen, Anke Schilhabel, Monika Brüggemann, Stephan Stilgenbauer, Barbara Eichhorst, Michael Hallek, Paula Cramer
Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial. Blood 144 (3) (2024)
Emma Kroeze, Ingram Iaccarino, Michelle M Kleisman, Mayukh Mondal, Thomas Beder, Mouhamad Khouja, Marc P Höppner, Marijn A Scheijde-Vermeulen, Lennart A Kester, Monika Brüggemann, Claudia D Baldus, Gunnar Cario, Reno S Bladergroen, Nathalie Garnier, Andishe Attarbaschi, Jaime Verdu-Amorós, Rosemary Sutton, Elizabeth A Macintyre, Kenneth Scholten, Laura Arias Padilla, Birgit Burkhardt, Auke Beishuizen, Monique L den Boer, Roland P Kuiper, Jan L C Loeffen, Judith M Boer, Wolfram Klapper
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma. Blood (2024)
Martin Neumann, Thomas Beder, Lorenz Bastian, Sonja Hänzelmann, Miriam Bultmann, Nadine Wolgast, Alina Hartmann, Heiko Trautmann, Jutta Ortiz-Tanchez, Cornelia Schlee, Michael Schroeder, Lars Fransecky, Sebastian Vosberg, Walter Fiedler, Nael Alakel, Lisa Heberling, Mustafa Kondakci, Michael Starck, Stefan Schwartz, Simon Raffel, Carsten Müller-Tidow, Folker Schneller, Albrecht Reichle, Thomas Burmeister, Philipp A Greif, Monika Brüggemann, Nicola Gökbuget, Claudia Dorothea Baldus
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols. Leukemia 38 (6) (2024)
Michaela Kotrová, Eva Froňková, Michael Svatoň, Daniela Drandi, Felix Schön, Patricia Hoogeveen, Jeremy Hancock, Aneta Skotnicova, Anke Schilhabel, Cornelia Eckert, Emmanuelle Clappier, Giovanni Cazzaniga, Beat W Schäfer, Jacques J M van Dongen, Matthias Ritgen, Christiane Pott, Vincent H J van der Velden, Jan Trka, Monika Brüggemann
The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category. Leukemia 38 (7) (2024)
Patrick Derigs, Maria-Luisa Schubert, Peter Dreger, Anita Schmitt, Schayan Yousefian, Simon Haas, Caroline Röthemeier, Brigitte Neuber, Angela Hückelhoven-Krauss, Monika Brüggemann, Helga Bernhard, Guido Kobbe, Albrecht Lindemann, Mathias Rummel, Birgit Michels, Felix Korell, Anthony D Ho, Carsten Muller-Tidow, Michael Schmitt
Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study. Leukemia (2024)
Martin Neumann, Thomas Beder, Lorenz Bastian, Sonja Hänzelmann, Miriam Bultmann, Nadine Wolgast, Alina Hartmann, Heiko Trautmann, Jutta Ortiz-Tanchez, Cornelia Schlee, Michael Schroeder, Lars Fransecky, Sebastian Vosberg, Walter Fiedler, Nael Alakel, Lisa Heberling, Mustafa Kondakci, Michael Starck, Stefan Schwartz, Simon Raffel, Carsten Müller-Tidow, Folker Schneller, Albrecht Reichle, Thomas Burmeister, Philipp A Greif, Monika Brüggemann, Nicola Gökbuget, Claudia Dorothea Baldus
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols. Leukemia 38 (6) (2024)
Michaela Kotrová, Eva Froňková, Michael Svatoň, Daniela Drandi, Felix Schön, Patricia Hoogeveen, Jeremy Hancock, Aneta Skotnicova, Anke Schilhabel, Cornelia Eckert, Emmanuelle Clappier, Giovanni Cazzaniga, Beat W Schäfer, Jacques J M van Dongen, Matthias Ritgen, Christiane Pott, Vincent H J van der Velden, Jan Trka, Monika Brüggemann
The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category. Leukemia 38 (7) (2024)
Michaela Kotrová, Eva Froňková, Michael Svatoň, Daniela Drandi, Felix Schön, Patricia Hoogeveen, Jeremy Hancock, Aneta Skotnicova, Anke Schilhabel, Cornelia Eckert, Emmanuelle Clappier, Giovanni Cazzaniga, Beat W Schäfer, Jacques J M van Dongen, Matthias Ritgen, Christiane Pott, Vincent H J van der Velden, Jan Trka, Monika Brüggemann
The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category. Leukemia 38 (7) (2024)
Emma Kroeze, Ingram Iaccarino, Michelle M Kleisman, Mayukh Mondal, Thomas Beder, Mouhamad Khouja, Marc P Höppner, Marijn A Scheijde-Vermeulen, Lennart A Kester, Monika Brüggemann, Claudia D Baldus, Gunnar Cario, Reno S Bladergroen, Nathalie Garnier, Andishe Attarbaschi, Jaime Verdu-Amorós, Rosemary Sutton, Elizabeth Macintyre, Kenneth Scholten, Laura Arias Padilla, Birgit Burkhardt, Auke Beishuizen, Monique L den Boer, Roland P Kuiper, Jan L C Loeffen, Judith M Boer, Wolfram Klapper
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma. Blood 144 (1) (2024)
Lorenz Bastian, Thomas Beder, Malwine Jeanette Barz, Sonja Bendig, Lorenz Bartsch, Wencke Walter, Nadine Wolgast, Björn Brändl, Christian Rohrandt, Björn-Thore Hansen, Alina M Hartmann, Katharina Iben, Dennis Das Gupta, Miriam Denker, Johannes Zimmermann, Michael Wittig, Guranda Chitadze, Martin Neumann, Folker Schneller, Walter Fiedler, Björn Steffen, Matthias Stelljes, Christoph Faul, Stefan Schwartz, Franz-Josef Müller, Gunnar Cario, Lana Harder, Claudia Haferlach, Heike Pfeifer, Nicola Gökbuget, Monika Brüggemann, Claudia D Baldus
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL. Blood 143 (14) (2024)
Martin Neumann, Thomas Beder, Lorenz Bastian, Sonja Hänzelmann, Miriam Bultmann, Nadine Wolgast, Alina Hartmann, Heiko Trautmann, Jutta Ortiz-Tanchez, Cornelia Schlee, Michael Schroeder, Lars Fransecky, Sebastian Vosberg, Walter Fiedler, Nael Alakel, Lisa Heberling, Mustafa Kondakci, Michael Starck, Stefan Schwartz, Simon Raffel, Carsten Müller-Tidow, Folker Schneller, Albrecht Reichle, Thomas Burmeister, Philipp A Greif, Monika Brüggemann, Nicola Gökbuget, Claudia Dorothea Baldus
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols. Leukemia 38 (6) (2024)
Barbara Buldini, Elena Varotto, Margarita Maurer-Granofszky, Giuseppe Gaipa, Angela Schumich, Monika Brüggemann, Ester Mejstrikova, Giovanni Cazzaniga, Ondrej Hrusak, Monika Szczepanowski, Pamela Scarparo, Martin Zimmermann, Sabine Strehl, Dagmar Schinnerl, Marketa Zaliova, Leonid Karawajew, Jean-Pierre Bourquin, Tamar Feuerstein, Gunnar Cario, Julia Alten, Anja Möricke, Alessandra Biffi, Rosanna Parasole, Franca Fagioli, Maria Grazia Valsecchi, Andrea Biondi, Franco Locatelli, Andishe Attarbaschi, Martin Schrappe, Valentino Conter, Giuseppe Basso, Michael N Dworzak
CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment. Blood 143 (17) (2024)
Barbara Buldini, Elena Varotto, Margarita Maurer-Granofszky, Giuseppe Gaipa, Angela Schumich, Monika Brüggemann, Ester Mejstrikova, Giovanni Cazzaniga, Ondrej Hrusak, Monika Szczepanowski, Pamela Scarparo, Martin Zimmermann, Sabine Strehl, Dagmar Schinnerl, Marketa Zaliova, Leonid Karawajew, Jean-Pierre Bourquin, Tamar Feuerstein, Gunnar Cario, Julia Alten, Anja Möricke, Alessandra Biffi, Rosanna Parasole, Franca Fagioli, Maria Grazia Valsecchi, Andrea Biondi, Franco Locatelli, Andishe Attarbaschi, Martin Schrappe, Valentino Conter, Giuseppe Basso, Michael N Dworzak
CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment. Blood (2024)
Lorenz Bastian, Thomas Beder, Malwine Jeanette Barz, Sonja Bendig, Lorenz Bartsch, Wencke Walter, Nadine Wolgast, Björn Brändl, Christian Rohrandt, Björn-Thore Hansen, Alina M Hartmann, Katharina Iben, Dennis Das Gupta, Miriam Denker, Johannes Zimmermann, Michael Wittig, Guranda Chitadze, Martin Neumann, Folker Schneller, Walter Fiedler, Björn Steffen, Matthias Stelljes, Christoph Faul, Stefan Schwartz, Franz-Josef Müller, Gunnar Cario, Lana Harder, Claudia Haferlach, Heike Pfeifer, Nicola Gökbuget, Monika Brüggemann, Claudia D Baldus
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL. Blood 143 (14) (2024)
Moritz Fürstenau, Adam Giza, Jonathan Weiss, Fanni Kleinert, Sandra Robrecht, Fabian Franzen, Janina Stumpf, Petra Langerbeins, Othman Al-Sawaf, Florian Simon, Anna-Maria Fink, Christof Schneider, Eugen Tausch, Johannes Schetelig, Peter Dreger, Sebastian Böttcher, Kirsten Fischer, Karl-Anton Kreuzer, Matthias Ritgen, Anke Schilhabel, Monika Brüggemann, Stephan Stilgenbauer, Barbara Eichhorst, Michael Hallek, Paula Cramer
Acalabrutinib, venetoclax and obinutuzumab in relapsed CLL: Final efficacy and ctDNA analysis of the CLL2-BAAG trial. Blood (2024)
Lorenz Bastian, Thomas Beder, Malwine Jeanette Barz, Sonja Bendig, Lorenz Bartsch, Wencke Walter, Nadine Wolgast, Björn Brändl, Christian Rohrandt, Björn-Thore Hansen, Alina M Hartmann, Katharina Iben, Dennis Das Gupta, Miriam Denker, Johannes Zimmermann, Michael Wittig, Guranda Chitadze, Martin Neumann, Folker Schneller, Walter Fiedler, Björn Steffen, Matthias Stelljes, Christoph Faul, Stefan Schwartz, Franz-Josef Müller, Gunnar Cario, Lana Harder, Claudia Haferlach, Heike Pfeifer, Nicola Gökbuget, Monika Brüggemann, Claudia D Baldus
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL. Blood 143 (14) (2024)
Barbara Buldini, Elena Varotto, Margarita Maurer-Granofszky, Giuseppe Gaipa, Angela Schumich, Monika Brüggemann, Ester Mejstrikova, Giovanni Cazzaniga, Ondrej Hrusak, Monika Szczepanowski, Pamela Scarparo, Martin Zimmermann, Sabine Strehl, Dagmar Schinnerl, Marketa Zaliova, Leonid Karawajew, Jean-Pierre Bourquin, Tamar Feuerstein, Gunnar Cario, Julia Alten, Anja Möricke, Alessandra Biffi, Rosanna Parasole, Franca Fagioli, Maria Grazia Valsecchi, Andrea Biondi, Franco Locatelli, Andishe Attarbaschi, Martin Schrappe, Valentino Conter, Giuseppe Basso, Michael N Dworzak
CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment. Blood (2024)
Martin Neumann, Thomas Beder, Lorenz Bastian, Sonja Hänzelmann, Miriam Bultmann, Nadine Wolgast, Alina Hartmann, Heiko Trautmann, Jutta Ortiz-Tanchez, Cornelia Schlee, Michael Schroeder, Lars Fransecky, Sebastian Vosberg, Walter Fiedler, Nael Alakel, Lisa Heberling, Mustafa Kondakci, Michael Starck, Stefan Schwartz, Simon Raffel, Carsten Müller-Tidow, Folker Schneller, Albrecht Reichle, Thomas Burmeister, Philipp A Greif, Monika Brüggemann, Nicola Gökbuget, Claudia Dorothea Baldus
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols. Leukemia 38 (6) (2024)
Michaela Kotrová, Eva Froňková, Michael Svatoň, Daniela Drandi, Felix Schön, Patricia Hoogeveen, Jeremy Hancock, Aneta Skotnicova, Anke Schilhabel, Cornelia Eckert, Emmanuelle Clappier, Giovanni Cazzaniga, Beat W Schäfer, Jacques J M van Dongen, Matthias Ritgen, Christiane Pott, Vincent H J van der Velden, Jan Trka, Monika Brüggemann
The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category. Leukemia 38 (7) (2024)
Lorenz Bastian, Thomas Beder, Malwine Jeanette Barz, Sonja Bendig, Lorenz Bartsch, Wencke Walter, Nadine Wolgast, Björn Brändl, Christian Rohrandt, Björn-Thore Hansen, Alina M Hartmann, Katharina Iben, Dennis Das Gupta, Miriam Denker, Johannes Zimmermann, Michael Wittig, Guranda Chitadze, Martin Neumann, Folker Schneller, Walter Fiedler, Björn Steffen, Matthias Stelljes, Christoph Faul, Stefan Schwartz, Franz-Josef Müller, Gunnar Cario, Lana Harder, Claudia Haferlach, Heike Pfeifer, Nicola Gökbuget, Monika Brüggemann, Claudia D Baldus
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL. Blood 143 (14) (2024)
Lorenz Bastian, Thomas Beder, Malwine Jeanette Barz, Sonja Bendig, Lorenz Bartsch, Wencke Walter, Nadine Wolgast, Björn Brändl, Christian Rohrandt, Björn-Thore Hansen, Alina M Hartmann, Katharina Iben, Dennis Das Gupta, Miriam Denker, Johannes Zimmermann, Michael Wittig, Guranda Chitadze, Martin Neumann, Folker Schneller, Walter Fiedler, Björn Steffen, Matthias Stelljes, Christoph Faul, Stefan Schwartz, Franz-Josef Müller, Gunnar Cario, Lana Harder, Claudia Haferlach, Heike Pfeifer, Nicola Gökbuget, Monika Brüggemann, Claudia D Baldus
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL. Blood (2023)
Lorenz Bastian, Thomas Beder, Malwine Jeanette Barz, Sonja Bendig, Lorenz Bartsch, Wencke Walter, Nadine Wolgast, Björn Brändl, Christian Rohrandt, Björn-Thore Hansen, Alina M Hartmann, Katharina Iben, Dennis Das Gupta, Miriam Denker, Johannes Zimmermann, Michael Wittig, Guranda Chitadze, Martin Neumann, Folker Schneller, Walter Fiedler, Björn Steffen, Matthias Stelljes, Christoph Faul, Stefan Schwartz, Franz-Josef Müller, Gunnar Cario, Lana Harder, Claudia Haferlach, Heike Pfeifer, Nicola Gökbuget, Monika Brüggemann, Claudia D Baldus
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL. Blood (2023)
Guranda Chitadze, Anna Stengel, Cathrin John-Klaua, Julien-Alexander Bruckmüller, Heiko Trautmann, Michaela Kotrova, Franziska Darzentas, Miriam Kelm, Karol Pal, Nikos Darzentas, Lorenz Bastian, Britta Kehden, Wiebke Wessels, Aeint-Steffen Ströh, Hans-Heinrich Oberg, Philipp M Altrock, Constance Baer, Manja Meggendorfer, Claudia Haferlach, Nicola Goekbuget, Claudia D Baldus, Monika Brüggemann
Somatic TP53 mutations are pre-leukemic events in acute lymphoblastic leukemia. Blood (2022)
Michaela Kotrová, Johannes Koopmann, Heiko Trautmann, Nael Alakel, Joachim Beck, Kathrin Nachtkamp, Björn Steffen, Simon Raffel, Andreas Viardot, Klaus Wethmar, Nikos Darzentas, Claudia D Baldus, Nicola Gökbuget, Monika Brüggemann
Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods. Blood advances 6 (10) (2022)
Michael Svatoň, Aneta Skotnicova, Leona Reznickova, Andrea Rennerova, Tatana Valova, Michaela Kotrová, Vincent H J van der Velden, Monika Brüggemann, Nikos Darzentas, Anton W Langerak, Jan Zuna, Jan Stary, Jan Trka, Eva Froňková
NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol. Blood (2022)
James Peter Stewart, Jana Gazdova, Nikos Darzentas, Dörte Wren, Paula Proszek, Grazia Fazio, Simona Songia, Miguel Alcoceba, María Eugenia Sarasquete, Patrick Villarese, Michèle Y van der Klift, Kim C Heezen, Neil McCafferty, Karol Pal, Mark Catherwood, Chang Sik Kim, Shambhavi Srivastava, Leonie I Kroeze, Elizabeth Hodges, Kostas Stamatopoulos, Wolfram Klapper, Elisa Genuardi, Simone Ferrero, Michiel van den Brand, Giovanni Cazzaniga, Frederic Davi, Lesley-Ann Sutton, Miriam Santero, Patricia J T A Groenen, Elizabeth A Macintyre, Monika Brüggemann, Christiane Pott, Anton W Langerak, David Gonzalez, null null
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders. Blood advances 5 (16) (2021)
Michaela Kotrova, Jan Trka, Michael Kneba, Monika Brüggemann
Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia? Molecular diagnosis & therapy 21 (5) (2018)
Anton W Langerak, Matthias Ritgen, Valentin Goede, Sandra Robrecht, Jasmin Bahlo, Kirsten Fischer, Michael Steurer, Marek Trněný, Stephen P Mulligan, Ulrich J M Mey, Kerstin Trunzer, Günter Fingerle-Rowson, Kathryn Humphrey, Stephan Stilgenbauer, Sebastian Böttcher, Monika Brüggemann, Michael Hallek, Michael Kneba, Jacques J M van Dongen
Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab. Blood 133 (5) (2018)
Nicola Gökbuget, Hervé Dombret, Massimiliano Bonifacio, Albrecht Reichle, Carlos Graux, Christoph Faul, Helmut Diedrich, Max S Topp, Monika Brüggemann, Heinz-August Horst, Violaine Havelange, Julia Stieglmaier, Hendrik Wessels, Vincent Haddad, Jonathan E Benjamin, Gerhard Zugmaier, Dirk Nagorsen, Ralf Christian Bargou
Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia. Blood 131 (14) (2018)
Monika Brüggemann, Michaela Kotrová
Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation. Blood advances 1 (25) (2017)

Monika Brüggemann.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Monika Brüggemann